GENERIC NAME OF THE MEDICINAL PRODUCT:
Letrozole Tablets USP 2.5mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Letrozole Tablets USP 2.5mg
Each film-coated tablet contains:
Letrozole USP……………….2.5 mg
Excipients………………………q.s.
Colours: Titanium Dioxide USP
Each film-coated tablet contains:
Letrozole USP……………….2.5 mg
Excipients………………………q.s.
Colours: Titanium Dioxide USP
THERAPEUTIC INDICATIONS:
Letrozole is a medicine used for treating breast cancer. It can also help prevent breast cancer from coming back. It is mainly prescribed for women who have been through the menopause and have a type of cancer called "hormone-dependent" breast cancer.
CAUTION & WARNING:
CAUTION: It is dangerous to take this preparation except under medical supervision.
WARNING: Cytotoxic Agent: To be sold by retail on the prescription of an oncologist/ Cancer Hospital/ Institution only.
Dispense in tight container (USP)
Keep out of reach and sight of children.
Swallow complete tablet, do not crush or chew.
WARNING: Cytotoxic Agent: To be sold by retail on the prescription of an oncologist/ Cancer Hospital/ Institution only.
Dispense in tight container (USP)
Keep out of reach and sight of children.
Swallow complete tablet, do not crush or chew.
STORAGE & DOSAGE:
Storage: Store at 25°C (77° F); excursions permitted to 15°C to 30°C (59 to 86° F) [see USP Controlled Room Temperature].
Dosage: As directed by Oncologist.
For Oral use. Read the package insert before use.
Dosage: As directed by Oncologist.
For Oral use. Read the package insert before use.
Letrozole Tablets USP 2.5mg (Lytrofem) Technical Specification:
| Product Name: | Letrozole Tablets USP 2.5mg |
| Brand Name: | Lytrofem |
| Strength: | 2.5mg |
| Dosage Form: | Film-coated Tablets |
| Packing: | 5s, 10s, 30s, 100s |
| Route of Administration: | For Oral Use only. |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) |
| Regulatory Documents: | COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier |
| Therapeutic use: | Anti-Cancer |
| Indication: | Letrozole is a medicine used for treating breast cancer. It can also help prevent breast cancer from coming back. It is mainly prescribed for women who have been through the menopause and have a type of cancer called “hormone-dependent” breast cancer. |
| Storage: | Store at 25°C (77° F); excursions permitted to 15°C to 30°C (59 to 86° F) [see USP Controlled Room Temperature]. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Letrozole Tablets USP 2.5mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Letrozole Tablets USP 2.5mg
Each film-coated tablet contains:
Letrozole USP……………….2.5 mg
Excipients………………………q.s.
Colours: Titanium Dioxide USP
THERAPEUTIC INDICATIONS:
Letrozole is a medicine used for treating breast cancer. It can also help prevent breast cancer from coming back. It is mainly prescribed for women who have been through the menopause and have a type of cancer called “hormone-dependent” breast cancer.
CAUTION & WARNING:
CAUTION: It is dangerous to take this preparation except under medical supervision.
WARNING: Cytotoxic Agent: To be sold by retail on the prescription of an oncologist/ Cancer Hospital/ Institution only.
Dispense in tight container (USP)
Keep out of reach and sight of children.
Swallow complete tablet, do not crush or chew.
STORAGE & DOSAGE:
Storage: Store at 25°C (77° F); excursions permitted to 15°C to 30°C (59 to 86° F) [see USP Controlled Room Temperature].
Dosage: As directed by Oncologist.
For Oral use. Read the package insert before use.
